DWJ211

DRUG3 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

HealthySubmental FatTreatment for Submental Fat

Phase 1

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

CompletedNCT04159961

Daewoong Pharmaceutical Co. LTD.Healthy

Start: 2019-12-24End: 2020-04-21Updated: 2024-04-04

Phase 2

Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

CompletedNCT03224117

Daewoong Pharmaceutical Co. LTD.Treatment for Submental Fat

Start: 2017-10-26End: 2018-06-29Updated: 2024-04-04

Phase 3

Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

CompletedNCT03946592

Daewoong Pharmaceutical Co. LTD.Submental Fat

Start: 2019-05-15End: 2020-07-02Updated: 2024-04-04